{"action":[{"action":[{"description":"Will offer Naloxone instead"},{"description":"Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo"},{"description":"N/A - see comment; snooze 3 mo"}],"condition":[{"expression":{"description":"Check whether the existing patient exhibits risk factors for opioid-related harms, such as concurrent use with benzodiazepine, a history of substance abuse, and/or an average MME greater than 50 mg/day.","expression":"Inclusion Criteria","language":"text/cql"},"kind":"applicability"}],"description":"Checking if the trigger prescription meets the inclusion criteria for recommendation #8 workflow.","documentation":[{"document":{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/cqf-strengthOfRecommendation","valueCodeableConcept":{"coding":[{"code":"strong","display":"Strong","system":"http://terminology.hl7.org/CodeSystem/recommendation-strength"}]}},{"url":"http://hl7.org/fhir/StructureDefinition/cqf-qualityOfEvidence","valueCodeableConcept":{"coding":[{"code":"low","display":"Low quality","system":"http://terminology.hl7.org/CodeSystem/evidence-quality"}]}}]},"type":"documentation"}],"dynamicValue":[{"expression":{"expression":"Get Detail","language":"text/cql"},"path":"action.description"},{"expression":{"expression":"Get Summary","language":"text/cql"},"path":"action.title"},{"expression":{"expression":"Get Indicator","language":"text/cql"},"path":"action.extension"}],"groupingBehavior":"visual-group","selectionBehavior":"exactly-one","title":"Existing patient exhibits risk factors for opioid-related harms.","trigger":[{"name":"medication-prescribe","type":"named-event"}]}],"author":[{"name":"Kensaku Kawamoto, MD, PhD, MHS"},{"name":"Bryn Rhodes"},{"name":"Floyd Eisenberg, MD, MPH"},{"name":"Robert McClure, MD, MPH"}],"contact":[{"telecom":[{"system":"url"}]}],"copyright":"© CDC 2016+.","date":"2018-03-19","description":"Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"cds"}],"id":"opioidcds-08","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.4.642.11.10"},{"use":"official","value":"cdc-opioid-guidance"}],"jurisdiction":[{"coding":[{"code":"US","display":"United States of America","system":"urn:iso:std:iso:3166"}]}],"library":["http://example.org/fhir/Library/opioidcds-recommendation-08"],"name":"Cdcopioid08","publisher":"HL7 International / Clinical Decision Support","purpose":"CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.","relatedArtifact":[{"display":"CDC guideline for prescribing opioids for chronic pain","document":{"url":"https://guidelines.gov/summaries/summary/50153/cdc-guideline-for-prescribing-opioids-for-chronic-pain---united-states-2016#420"},"type":"documentation"},{"display":"MME Conversion Tables","document":{"url":"https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf"},"type":"documentation"}],"resourceType":"PlanDefinition","status":"draft","text":{"div":"
Generated Narrative: PlanDefinition
Resource PlanDefinition "opioidcds-08"
StructureDefinition Work Group: cds
url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-08
identifier: URI/urn:oid:2.16.840.1.113883.4.642.11.10, cdc-opioid-guidance\u00a0(use:\u00a0OFFICIAL)
version: 0.1.0
name: Cdcopioid08
title: CDC Opioid Prescribing Guideline Recommendation #8
type: ECA Rule (PlanDefinitionType#eca-rule)
status: draft
date: 2018-03-19
publisher: HL7 International / Clinical Decision Support
contact:
description: Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.
- | Code | Value[x] |
* | Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus') | Medication requested (situation) (SNOMED CT#182888003) |
* | Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus') | Chronic pain (finding) (SNOMED CT#82423001) |
jurisdiction: United States of America (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#US)
purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.
usage: Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.
copyright: © CDC 2016+.
topic: Opioid Prescribing ()
author: Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:
relatedArtifact
type: documentation
display: CDC guideline for prescribing opioids for chronic pain
document
relatedArtifact
type: documentation
display: MME Conversion Tables
document
library: http://example.org/fhir/Library/opioidcds-recommendation-08
action
title: Existing patient exhibits risk factors for opioid-related harms.
description: Checking if the trigger prescription meets the inclusion criteria for recommendation #8 workflow.
documentation
type: documentation
document
Triggers
- Type Name * named-event medication-prescribe condition
kind: applicability
Expressions
- Description Language Expression * Check whether the existing patient exhibits risk factors for opioid-related harms, such as concurrent use with benzodiazepine, a history of substance abuse, and/or an average MME greater than 50 mg/day. text/cql Inclusion Criteria groupingBehavior: visual-group
selectionBehavior: exactly-one
dynamicValue
path: action.description
Expressions
- Language Expression * text/cql Get Detail dynamicValue
path: action.title
Expressions
- Language Expression * text/cql Get Summary dynamicValue
path: action.extension
Expressions
- Language Expression * text/cql Get Indicator Actions
- Description * Will offer Naloxone instead * Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo * N/A - see comment; snooze 3 mo